.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Accenture
Express Scripts
AstraZeneca
McKinsey
US Army
US Department of Justice
QuintilesIMS
Dow
Fuji

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Topical composition for inhibiting hair growth
Abstract:The present invention embraces a topical composition for inhibiting mammalian hair growth, particularly human beard hair growth (including hirsutism), comprising a water-soluble, hair-growth-inhibiting agent dispersed in an oil-in-water emulsion in the form of a lotion or cream. The invention also embraces a method of inhibiting mammalian hair growth by applying an effective amount of the above composition to the skin. The invention further embraces a topical composition for delivering a pharmacological agent to the skin.
Inventor(s): Boxall; Brian Alfred (Berkshire RG11 5EU, GB), Amery; Geoffrey Wilfred (Berkshire RG6 1HN, GB), Ahluwalia; Gurpreet S. (Gaithersburg, MD)
Assignee:
Application Number:08/513,980
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

No matches for this query

Foreign Priority and PCT Information for Patent: ► Subscribe

PCT Information
PCT FiledMay 27, 1993PCT Application Number:PCT/US93/05068
PCT Publication Date:September 29, 1994PCT Publication Number: WO94/21217

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria172871► Subscribe
Australia3931093► Subscribe
Australia4524393► Subscribe
Australia684251► Subscribe
Canada2158041► Subscribe
China1093755► Subscribe
China1097982► Subscribe
Germany69321974► Subscribe
Denmark0689416► Subscribe
European Patent Office0689416► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chubb
AstraZeneca
Farmers Insurance
Argus Health
US Department of Justice
Novartis
Accenture
Citi
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot